Showing papers by "Martin Pelletier published in 2018"

TL;DR: An article suggesting a critical role for S100A9 and neutrophils in granuloma formation was published recently in Blood Advances and the authors used tasquinimod to block S hundredA9 activity and referred to it as an S 100A9 inhibitor.